Correlation Between Wuhan Hvsen and Contemporary Amperex
Specify exactly 2 symbols:
By analyzing existing cross correlation between Wuhan Hvsen Biotechnology and Contemporary Amperex Technology, you can compare the effects of market volatilities on Wuhan Hvsen and Contemporary Amperex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Wuhan Hvsen with a short position of Contemporary Amperex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Wuhan Hvsen and Contemporary Amperex.
Diversification Opportunities for Wuhan Hvsen and Contemporary Amperex
0.93 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Wuhan and Contemporary is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Wuhan Hvsen Biotechnology and Contemporary Amperex Technolog in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Contemporary Amperex and Wuhan Hvsen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Wuhan Hvsen Biotechnology are associated (or correlated) with Contemporary Amperex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Contemporary Amperex has no effect on the direction of Wuhan Hvsen i.e., Wuhan Hvsen and Contemporary Amperex go up and down completely randomly.
Pair Corralation between Wuhan Hvsen and Contemporary Amperex
Assuming the 90 days trading horizon Wuhan Hvsen Biotechnology is expected to generate 0.84 times more return on investment than Contemporary Amperex. However, Wuhan Hvsen Biotechnology is 1.19 times less risky than Contemporary Amperex. It trades about 0.22 of its potential returns per unit of risk. Contemporary Amperex Technology is currently generating about 0.15 per unit of risk. If you would invest 835.00 in Wuhan Hvsen Biotechnology on September 5, 2024 and sell it today you would earn a total of 461.00 from holding Wuhan Hvsen Biotechnology or generate 55.21% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Wuhan Hvsen Biotechnology vs. Contemporary Amperex Technolog
Performance |
Timeline |
Wuhan Hvsen Biotechnology |
Contemporary Amperex |
Wuhan Hvsen and Contemporary Amperex Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Wuhan Hvsen and Contemporary Amperex
The main advantage of trading using opposite Wuhan Hvsen and Contemporary Amperex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Wuhan Hvsen position performs unexpectedly, Contemporary Amperex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Contemporary Amperex will offset losses from the drop in Contemporary Amperex's long position.Wuhan Hvsen vs. Fujian Anjoy Foods | Wuhan Hvsen vs. Great Sun Foods Co | Wuhan Hvsen vs. Beijing Sanyuan Foods | Wuhan Hvsen vs. Muyuan Foodstuff Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Global Correlations Find global opportunities by holding instruments from different markets | |
CEOs Directory Screen CEOs from public companies around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |